Log in or Sign up for Free to view tailored content for your specialty!
Hidradenitis Suppurativa News
Physician shares alternative medicine practices for hidradenitis suppurativa
SAN DIEGO — The implementation of dietary modifications, supplementation and other lifestyle changes can significantly improve hidradenitis suppurativa, according to a speaker here.
European Medicines Agency recommends Bimzelx for hidradenitis suppurativa treatment
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended marketing authorization for Bimzelx in the European Union and European Economic Area for hidradenitis suppurativa, UCB announced in a press release.
Log in or Sign up for Free to view tailored content for your specialty!
‘There are options’: Managing hidradenitis suppurativa during pregnancy
SAN DIEGO — It is important for both patients and dermatologists to know that there are options for the management of hidradenitis suppurativa during pregnancy, according to a speaker at the American Academy of Dermatology Annual Meeting.
Izokibep meets ACR50 endpoint in PsA, has ‘deepening’ benefit in hidradenitis suppurativa
Izokibep achieved the primary endpoint of ACR50 response in a phase 2b/3 psoriatic arthritis trial, and demonstrated sustained, “deepening” benefit in hidradenitis suppurativa, according to top-line data from its manufacturer.
Patients with unresponsive hidradenitis suppurativa find relief with lutikizumab 300 mg
SAN DIEGO — Lutikizumab showed positive results in the treatment of patients with hidradenitis suppurativa that failed anti-TNF treatment, according to a late-breaking presentation at the 2024 American Academy of Dermatology Annual Meeting.
Intravenous ertapenem improves hidradenitis suppurativa inflammation, patient satisfaction
The use of intravenous antibiotics, specifically ertapenem, was associated with improvement in inflammatory markers in patients with hidradenitis suppurativa, according to a study.
Pretreatment testing rates for patients with skin diseases may diverge from guidelines
Data showed that not all patients with chronic inflammatory skin diseases undergo pretreatment testing before initiating systemic immunomodulatory therapies, despite current guidelines, according to a study.
JAK inhibitors have ‘untapped potential’ in treatment of inflammatory skin diseases
MIAMI BEACH, Fla. — Janus kinase inhibitors have a unique mechanism of action, giving them the potential to push the boundaries of efficacy in the treatment of inflammatory skin diseases, according to a speaker at South Beach Symposium.
Addressing patient concerns with biologic treatment in hidradenitis suppurativa
Patients with hidradenitis suppurativa are hesitant to use adalimumab — which is recommended as a first-line treatment for the skin condition — as well as other biologics, according to a study.
South Beach Symposium adds ‘unique session’ focused on holistic dermatologic treatment
In addition to cutting edge content, the 22nd annual South Beach Symposium has added a “unique session” that focuses on how the medical and cosmetic dermatologist can work together to holistically treat patients.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read